Rapid Screening, Binding Characterization or Developability Profiling: Which RushData Package Fits Your Program?

Antibody discovery programs can generate hundreds or thousands of candidate sequences, but each project requires different levels of experimental characterization.  

RushData offers three packages: Basic, Standard and Premium, designed to support these different stages of candidate evaluation. Each package combines high-throughput expression with a set of analytical assays and structured data outputs. The appropriate package depends on the scientific question being asked and the amount of characterization required.

1. Basic: Rapid Screening for Early Candidate Triage

The Basic package is intended for programs that need to compare a large number of candidates quickly using antibody-containing cell culture supernatant. 

A supernatant is the liquid collected from cultured cells after they have secreted the antibody. Because the antibody is evaluated without a separate purification step, supernatant-based screening can provide an efficient first look at expression and binding performance. 

The Basic package includes: 

• High-throughput expression in supernatant 

• Titer measurement by biolayer interferometry 

• Two-point affinity assessment by biolayer interferometry 

Titer refers to the amount of antibody produced in the cell culture. Affinity describes the strength of the interaction between an antibody and its target. 

Biolayer interferometry, or BLI, is a label-free analytical method that measures molecular interactions in real time. BLI can be used for antibody quantitation and for evaluating binding affinity and kinetics. In the Basic package, Biointron uses BLI for titer measurement and a two-point affinity assessment. 

When Basic may be appropriate

Basic is suited to early-stage programs in which the primary objective is to: 

• Identify candidates with measurable expression 

• Confirm initial target binding 

• Compare a large sequence panel 

• Remove weakly expressing or poorly binding candidates before purification 

• Generate an initial experimental dataset for candidate ranking 

Because the package uses supernatant and a two-point binding assessment, it is primarily a screening workflow rather than a complete analytical characterization package. 

2. Standard: Purified Antibodies and Binding Characterization

The Standard package is intended for programs that require purified antibodies and a more detailed dataset for comparing candidate quality and target binding. 

It includes: 

• High-throughput expression and purification 

• Antibody concentration measurement by A280 

• Non-reducing capillary gel electrophoresis 

• Multi-point affinity analysis by BLI or surface plasmon resonance 

The A280 method estimates protein concentration by measuring ultraviolet-light absorbance at 280 nanometers. This method is commonly used for purified protein samples because aromatic amino acids within proteins absorb light at this wavelength. 

Non-reducing capillary gel electrophoresis, or cGE, separates protein species according to their movement through a gel-filled capillary. Under non-reducing conditions, the antibody’s disulfide bonds remain intact. The method can be used to assess intact antibody purity and detect lower-molecular-weight species such as fragments. 

For binding characterization, the Standard package uses multi-point BLI or surface plasmon resonance. Surface plasmon resonance, or SPR, is a label-free technique that monitors molecular interactions at a sensor surface in real time and can provide information about binding affinity and kinetics. 

When Standard may be appropriate

Standard is suited to programs that need to: 

• Compare purified antibody candidates 

• Measure antibody concentration 

• Assess intact antibody purity 

• Obtain more detailed affinity data 

• Select candidates for functional testing or further optimization 

• Generate a consistent dataset across expression, purity and binding measurements 

Standard provides a broader analytical view than supernatant-level screening while remaining focused on expression quality and target binding. 

3. Premium: Developability Profiling for Lead Prioritization

Strong expression and target binding do not, by themselves, establish that an antibody has favorable properties for continued development. Candidates can also differ in thermal stability, nonspecific binding and their tendency to interact with themselves. 

These characteristics are part of antibody developability: the collection of molecular and biophysical properties that can influence whether an antibody can be produced, formulated and advanced successfully. 

The Premium package includes all Standard assays, plus: 

• Differential scanning fluorimetry for onset and melting temperatures 

• PSR-BVP polyreactivity assessment 

• AC-SINS self-interaction analysis 

Differential scanning fluorimetry, or DSF, monitors changes in protein fluorescence as temperature increases and the protein begins to unfold. The assay provides values including the onset temperature, or T_onset, and melting temperature, or T_m, which help compare the thermal stability of antibody candidates. 

The PSR-BVP assay evaluates polyreactivity—the tendency of an antibody to interact with multiple unrelated biological materials rather than binding only to its intended target. RushData uses this assay as an early indicator of nonspecific-binding liability. 

Affinity-capture self-interaction nanoparticle spectroscopy, or AC-SINS, evaluates an antibody’s tendency to interact with other molecules of the same antibody. The method was developed to identify self-association liabilities using relatively low antibody concentrations and has been adapted for high-throughput screening during early antibody discovery. 

When Premium may be appropriate 

Premium is suited to programs that need to: 

• Rank leads using both binding and developability data 

• Identify candidates with lower thermal stability 

• Detect potential polyreactivity 

• Compare antibody self-interaction propensity 

• Generate multidimensional data for computational analysis 

• Reduce the number of higher-risk candidates entering later studies 

The package is particularly relevant when several candidates have similar affinity but differ in the properties that may affect later development. 

Comparing the Three Packages

The package choice can therefore be guided by a straightforward question: 

• Choose Basic when the immediate goal is rapid triage across a large candidate panel. 

• Choose Standard when purified antibodies, purity information and more detailed binding characterization are required. 

• Choose Premium when lead selection also depends on thermal stability, polyreactivity and self-interaction risk. 

Matching Data Depth to the Discovery Stage

Not every candidate needs a full developability profile at the beginning of a program. A staged strategy can begin with rapid supernatant screening, followed by purified-antibody characterization for selected candidates and developability profiling for the most promising leads. 

Alternatively, programs designed to generate comprehensive training data may apply a broader package to a larger candidate set. RushData supports structured, multidimensional datasets that can be compared by scientists or returned to computational antibody design and optimization workflows. The platform is designed to support thousands of candidates in parallel, with capacity for more than 3,000 molecules per batch. Exact turnaround depends on candidate count, package selection and the requested assays. 

Selecting the appropriate RushData package is therefore not simply a choice between more or fewer assays. It is a decision about which experimental evidence is needed at the current stage of the program: rapid screening, purified binding characterization or broader developability-based lead prioritization. 

RushData →